Advances in Eicosanoid Research

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Biotechnology
Cover of the book Advances in Eicosanoid Research by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg Publication: March 14, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg
Publication: March 14, 2013
Imprint: Springer
Language: English

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

More books from Springer Berlin Heidelberg

Cover of the book The Natural Environment and the Biogeochemical Cycles by
Cover of the book Remote Sensing of Soils by
Cover of the book Disability by
Cover of the book Mediterranean Climate by
Cover of the book Delay-Coupled Complex Systems by
Cover of the book Arztrecht by
Cover of the book Process Innovation: Enabling Change by Technology by
Cover of the book Functional Genomics and Biotechnology in Solanaceae and Cucurbitaceae Crops by
Cover of the book Plant Breeding for Abiotic Stress Tolerance by
Cover of the book Foundations of Geometric Algebra Computing by
Cover of the book Schein's Common Sense Emergency Abdominal Surgery by
Cover of the book Transactions on Large-Scale Data- and Knowledge-Centered Systems XIII by
Cover of the book Geochemistry at the Earth’s Surface by
Cover of the book Stochastische Risikomodellierung und statistische Methoden by
Cover of the book Gesundheit! by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy